[Experiences with the antiestrogen tamoxifen in the therapy of oligozoospermia]. 1981

W B Schill, and M Landthaler

Thirty-three subfertile men with idiopathic normogonadotropic oligozoospermia were treated with daily 2 x 10 mg tamoxifen, a nonsteroidal antiestrogen, for a period of five months. The statistical evaluation of the semen parameters yielded a significant increase of the sperm count and the total sperm output after three months of treatment with a further increase after five months. The percentage of motile spermatozoa increased already after one month and remained significantly increased during the whole treatment period. Progressive motility, sperm morphology, ejaculate volume and seminal plasma fructose were not affected. Side effects were not observed. The conception rate was 38 per cent within a period of one year.

UI MeSH Term Description Entries
D008297 Male Males
D009845 Oligospermia A condition of suboptimal concentration of SPERMATOZOA in the ejaculated SEMEN to ensure successful FERTILIZATION of an OVUM. In humans, oligospermia is defined as a sperm count below 20 million per milliliter semen. Cryptospermia,Cryptozoospermia,Low Sperm Count,Hypospermatogenesis,Oligoasthenoteratozoospermia,Oligozoospermia,Cryptospermias,Cryptozoospermias,Hypospermatogeneses,Low Sperm Counts,Oligoasthenoteratozoospermias,Sperm Count, Low,Sperm Counts, Low
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013076 Sperm Count A count of SPERM in the ejaculum, expressed as number per milliliter. Sperm Number,Count, Sperm,Counts, Sperm,Number, Sperm,Numbers, Sperm,Sperm Counts,Sperm Numbers
D013081 Sperm Motility Movement characteristics of SPERMATOZOA in a fresh specimen. It is measured as the percentage of sperms that are moving, and as the percentage of sperms with productive flagellar motion such as rapid, linear, and forward progression. Motilities, Sperm,Motility, Sperm,Sperm Motilities
D013629 Tamoxifen One of the SELECTIVE ESTROGEN RECEPTOR MODULATORS with tissue-specific activities. Tamoxifen acts as an anti-estrogen (inhibiting agent) in the mammary tissue, but as an estrogen (stimulating agent) in cholesterol metabolism, bone density, and cell proliferation in the ENDOMETRIUM. ICI-46,474,ICI-46474,ICI-47699,Nolvadex,Novaldex,Soltamox,Tamoxifen Citrate,Tomaxithen,Zitazonium,Citrate, Tamoxifen,ICI 46,474,ICI 46474,ICI 47699,ICI46,474,ICI46474,ICI47699

Related Publications

W B Schill, and M Landthaler
December 1982, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke,
W B Schill, and M Landthaler
March 1988, Ceskoslovenska gynekologie,
W B Schill, and M Landthaler
December 1977, Annals of internal medicine,
W B Schill, and M Landthaler
January 1981, European urology,
W B Schill, and M Landthaler
January 1985, Acta Europaea fertilitatis,
W B Schill, and M Landthaler
August 1979, The Journal of clinical investigation,
W B Schill, and M Landthaler
January 1988, European urology,
W B Schill, and M Landthaler
January 2012, Oncology nursing forum,
W B Schill, and M Landthaler
December 1988, Experimental and clinical endocrinology,
W B Schill, and M Landthaler
January 1985, Andrologia,
Copied contents to your clipboard!